Kura Oncology (KURA) News Today $6.47 -0.02 (-0.31%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$6.46 0.00 (-0.08%) As of 05/2/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Kura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsKura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsMay 4 at 10:50 AM | marketbeat.comKura Oncology (NASDAQ:KURA) Price Target Lowered to $11.00 at BarclaysBarclays lowered their price objective on Kura Oncology from $32.00 to $11.00 and set an "overweight" rating for the company in a research report on Friday.May 4 at 10:12 AM | marketbeat.comScotiabank Keeps Their Hold Rating on Kura Oncology (KURA)May 4 at 7:57 AM | theglobeandmail.comBTIG Keeps Their Hold Rating on Kura Oncology (KURA)May 4 at 7:57 AM | theglobeandmail.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Aquatic Capital Management LLCAquatic Capital Management LLC increased its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 327.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,917 shares of the company's stockMay 4 at 4:37 AM | marketbeat.comKura Oncology (NASDAQ:KURA) Downgraded by StockNews.com to "Hold"May 4 at 3:41 AM | americanbankingnews.comKura Oncology (NASDAQ:KURA) Shares Gap Down After Earnings MissMay 4 at 1:43 AM | americanbankingnews.comEarnings call transcript: Kura Oncology Q1 2025 reveals revenue boostMay 3 at 4:56 PM | investing.com4,451,041 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Acquired by RA Capital Management L.P.RA Capital Management L.P. acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,451,041 shares of the companyMay 3 at 7:49 AM | marketbeat.comQ1 2025 Kura Oncology Inc Earnings CallMay 2 at 3:25 PM | finance.yahoo.comKura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call TranscriptMay 2 at 10:25 AM | msn.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2 at 7:30 AM | globenewswire.comNebula Research & Development LLC Purchases Shares of 63,866 Kura Oncology, Inc. (NASDAQ:KURA)Nebula Research & Development LLC purchased a new stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 63,866 shares of the company's stock, vMay 2 at 5:03 AM | marketbeat.comTower Research Capital LLC TRC Acquires 46,613 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Tower Research Capital LLC TRC lifted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 889.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 51,852 shares of the company's stockMay 2 at 4:15 AM | marketbeat.comJMP Securities Reaffirms Market Outperform Rating for Kura Oncology (NASDAQ:KURA)May 2 at 3:35 AM | americanbankingnews.comKura Oncology, Inc. (KURA) Q1 2025 Earnings Call TranscriptMay 1 at 9:02 PM | seekingalpha.comKura Oncology Reports First Quarter 2025 Financial ResultsMay 1 at 4:17 PM | globenewswire.comKura Oncology's (KURA) Market Outperform Rating Reiterated at JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $28.00 price objective on shares of Kura Oncology in a research note on Tuesday.May 1 at 12:38 PM | marketbeat.comUncovering Potential: Kura Oncology's Earnings PreviewApril 30, 2025 | benzinga.comKura Oncology Q1 2025 Earnings PreviewApril 30, 2025 | msn.comKura Oncology (NASDAQ:KURA) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $40.00 price objective on shares of Kura Oncology in a research note on Monday.April 30, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Earns "Buy" Rating from HC WainwrightApril 30, 2025 | americanbankingnews.comKura doses first subjects in trial of ziftomenib for advanced GISTApril 29, 2025 | finance.yahoo.comKura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GISTApril 28, 2025 | globenewswire.comKura Oncology (KURA) Expected to Announce Quarterly Earnings on ThursdayKura Oncology (NASDAQ:KURA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-kura-oncology-inc-stock/)April 26, 2025 | marketbeat.com948,905 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Purchased by Marshall Wace LLPMarshall Wace LLP acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 948,905 shares of the company's stock, valued at approximately $8,265,000. MarsApril 25, 2025 | marketbeat.comKura Oncology to Report First Quarter 2025 Financial ResultsApril 24, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Shares Up 5.5% - What's Next?Kura Oncology (NASDAQ:KURA) Stock Price Up 5.5% - Time to Buy?April 23, 2025 | marketbeat.comAvoro Capital Advisors LLC Has $19.60 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)Avoro Capital Advisors LLC trimmed its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 36.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,250,000 shares of the company's stock after selling 1,291,505April 23, 2025 | marketbeat.comVoss Capital LP Takes $2.40 Million Position in Kura Oncology, Inc. (NASDAQ:KURA)Voss Capital LP acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 275,000 shares of the company's stock, valued at approximately $2,395,000April 23, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 43,320 Shares of Kura Oncology, Inc. (NASDAQ:KURA)JPMorgan Chase & Co. decreased its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 365,921 shares of the company's stock after selling 43,320 shares during the period. JPMorgApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Acquires 491,700 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Renaissance Technologies LLC increased its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 463.4% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 597,810 shares of the company's stock after buying an additional 491,700 shares duApril 22, 2025 | marketbeat.comJump Financial LLC Raises Position in Kura Oncology, Inc. (NASDAQ:KURA)Jump Financial LLC lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 862.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 239,933 shares of the company's stock after acquiring an additionApril 21, 2025 | marketbeat.com1492 Capital Management LLC Raises Holdings in Kura Oncology, Inc. (NASDAQ:KURA)1492 Capital Management LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 367.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 342,598 shares of the company's stock after purchasing an additApril 20, 2025 | marketbeat.comRussell Investments Group Ltd. Has $2.60 Million Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Russell Investments Group Ltd. lifted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 18.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 298,662 shares of the company's stock after buying an additional 45April 20, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,818,898 shares of the company's stock after purchasingApril 14, 2025 | marketbeat.comKura Oncology's (KURA) "Outperform" Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and issued a $36.00 price objective on shares of Kura Oncology in a report on Tuesday.April 10, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, sevenApril 10, 2025 | marketbeat.comExodusPoint Capital Management LP Buys 242,263 Shares of Kura Oncology, Inc. (NASDAQ:KURA)ExodusPoint Capital Management LP boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 440.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 297,234 shares of the company's stock after acquiring an additional 242,263 shApril 9, 2025 | marketbeat.comFranklin Resources Inc. Sells 49,809 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Franklin Resources Inc. trimmed its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,538,592 shares of the company's stock after selling 49,809 shares during thApril 9, 2025 | marketbeat.comKura Oncology, Kyowa Kirin announce submission of NDA for ziftomenib to FDAApril 8, 2025 | markets.businessinsider.comKura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDAApril 8, 2025 | globenewswire.comSyndax Pharmaceuticals: Down But Not OutApril 7, 2025 | seekingalpha.comRhenman & Partners Asset Management AB Has $2.74 Million Stake in Kura Oncology, Inc. (NASDAQ:KURA)Rhenman & Partners Asset Management AB raised its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 88.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 314,526 shares of the companyApril 7, 2025 | marketbeat.comTrexquant Investment LP Purchases 508,362 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Trexquant Investment LP grew its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 867.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 566,945 shares of the company's stock after purchasing an additionaApril 7, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Upgraded to "Buy" at StockNews.comStockNews.com upgraded shares of Kura Oncology from a "hold" rating to a "buy" rating in a research note on Friday.April 5, 2025 | marketbeat.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 4, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Reaches New 12-Month Low - Time to Sell?Kura Oncology (NASDAQ:KURA) Hits New 12-Month Low - Here's WhyApril 3, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Down 7.6% - Should You Sell?Kura Oncology (NASDAQ:KURA) Shares Down 7.6% - Time to Sell?April 1, 2025 | marketbeat.comKura Oncology to Participate in Stifel Targeted Oncology ForumApril 1, 2025 | globenewswire.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.270.73▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼286▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MTSR News MIRM News BHC News BEAM News NAMS News VCEL News BLTE News TARS News JANX News SDGR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhy Elon put $51 million into thisWhile fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...True Market Insiders | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURA Stock Free KURA Stock Alerts